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Extracellular vesicles (EVs) are a heterogeneous group of lipid 
bilayer enclosed particles found to be released by most, if not all, cells. 
To date EVs have been found to be present in most biological fluids as 
well as in the environment around us. These vesicles can efficiently 
carry and protect from degradation different biological molecules such 
as functionally active proteins, lipids, and nucleic acids. By transferring 
such molecules between cells, different EVs participate in a diversity of 
biological processes in health and disease such as inflammation, 
immune suppression, antigen presentation, tumor development, as well 
as in the transfer of genetic information, morphogens and signaling 
molecules. 
Given their ability to participate in the above biological 
processes and to transfer molecules among cells, EVs have become 
increasingly attractive to researchers from various disciplines for the 
development of novel diagnostic and therapeutic tools. As a 
consequence, the field of EV research has seen tremendous growth and 
an exponential increase in number of publications year after year which 
has profoundly impacted our understanding of intercellular 
communication, tumor and stem cell biology, inflammation, virology, 
circulating extracellular RNA and DNA research among other fields. 
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With this rapid growth in the amount of reports about EV 
biology some classification and nomenclature of different subsets of 
EVs has emerged. Although there is still some debate over the 
nomenclature used, most in the field utilize the classification of different 
EVs based on their biogenesis and size ranges as exosomes (EXOs) of 
approximately 100 nm in size, microvesicles (MVs) of 100 to 1000 nm 
in size, and apoptotic bodies (APOs) of more than 1000 nm in size. 
These three important subsets are depicted in Figure 1 but it is important 
to note that other terms may also be encountered in EV literature. Some 
of the other used terms for EVs will be described later but in most cases 
they simply represent alternative nomenclature that actually corresponds 
to one of these previously described subtypes with size ranges similar to 
Figure 1. Size ranges of different EV subtypes. György et al 2011 
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EXOs, MVs, or APOs.  
Despite of the fast growth experienced in the field of EVs there 
are still remain many questions to address about the fundamental 
characteristics of distinct EV subpopulations. One important limitation 
for the field is that there are still no universally accepted molecular 
markers with which to characterize EVs. Additionally, there are no gold 
standard EV isolation techniques. Because of these reasons some 
disparity exists in the literature in regards to the different isolation and 
characterization techniques used for various studies. Consequently, even 
if there is ample evidence clearly supporting the effects of EVs in many 
biological processes there are still some areas where the evidence is 
ambiguous due to dissimilar findings.  
Considering these important limitations in the field, the present 
work focused on improving existing EV characterization and detection 
techniques by introducing to the field new approaches based on lipid 





 In recent years the field of EV research has truly emerged as 
one of the fastest growing areas due to all these recent findings and 
more scientists from other areas continue to get interested and start 
exploring the functions of EVs in their respective fields. However, 
despite this rapid growth one concern is that in regards to some 
biological processes it seems that different reports have found 
discordant roles for EVs. Therefore, it might seem puzzling whether 
EVs are in fact beneficial or detrimental in various biological processes 
in health and disease. 
Some of the observed discordance in biological roles reported 
for EVs can be explained by the inherent differences among various 
subtypes of EVs simultaneously found in the body which can also be 
released by different cells possibly in different activation states. 
Furthermore, the EVs and their cargo can also undergo various post-
synthetic modifications or combine with other EVs or soluble molecules 
which can alter their biological effects. Thus, when comparing different 
studies showing effects of EVs in any biological process all these 
inherent biological differences should be accounted for as they may 
explain discordant results if each report is analyzing completely 
different EVs. 
Even if it may be that many of the discordances can be 
explained by biological differences among the studies EVs there are still 
some examples where various reports supposedly investigating the same 
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particles do not obtain comparable results. One such example can be 
found with reports of EVs released during remote ischemic 
preconditioning (RIPC) which were observed to either reduce or to have 
no effect in infarct sizes (Jeanneteau et al. 2012, Giricz et al. 2014, 
Yamaguchi et al. 2015).  Based on this problem, we believe that in such 
a rapidly growing field it is also very important to have sound 
methodology and controls with which to characterize the material that is 
being studied so that researchers can easily compare their results to each 
other. As the field currently stands that is not always the case as many 
groups utilize different isolation and characterization methods and there 
are still no universally accepted protocols and molecular markers for 
EVs. 
For these reasons, the work undertaken during this Ph.D. had 
the following objectives.  
I. Improve existing EV methodology. 
II. Introduce novel assays for EV analysis. 
III. Develop a workflow for the quantification of EV lipid content. 
IV. Investigate the protein to lipid ratio of the different EV 
subpopulations. 
V. Characterize the membrane lipid order of the different EV 
subpopulations. 
VI. Establish the detergent lysis sensitivity of EVs. 
By pursuing these objectives we attempt to develop methods 
which we believe will expand the existing toolkit for EV research and 
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 Jurkat (TIB-152) human T cell lymphoma, THP-1 (TIB202) 
human acute monocytic leukemia, U937 (CRL-1593.2) human 
histiocytic lymphoma, BV-2 murine microglia, and MH-S murine 
alveolar macrophage cell lines were cultured in RPMI-1640 or DMEM 
media containing 10% (v/v) fetal bovine serum (FBS), 2 mM glutamine, 
and 1% Antibiotic Antimycotic Solution (Ab/AM) at 37°C in 5% 
CO2/air and placed in serum free conditions 24 prior to EV isolation. 
Cell viability was always monitored by flow cytometry to be >90-95% 
as confirmed by staining with Annexin V FITC and propidium iodide 
(both from BD Biosciences, Franklin Lakes, NJ). Acid-citrate dextrose 
(ACD) anti-coagulated plasma as well as expiring platelet concentrates 
were also submitted for microvesicle and exosome isolation after 
removal of platelets. 
Three different EV subpopulations were isolated including 
APOs, MVs, and EXOs by the combination of gravity driven filtration 
and differential centrifugation. Initially cells were removed by 
centrifugation at 300 g for 10 mins, and then the supernatant was 
filtered by gravity through a 5 µm filter (Millipore) and submitted to a 
2,000 g centrifugation for 10 mins to pellet APOs. The supernatant was 
next filtered by gravity through a 0.8 µm filter (Millipore) and 
centrifuged at 12,600 g for 30 mins to pellet MVs. Finally, the 
supernatant was ultracentrifuged in an Optima MAX-XP bench top 
ultracentrifuge with MLA-55 rotor (Beckman Coulter Inc, Brea, CA) at 
100,000 g for 70 mins to pellet EXOs. To remove co-isolated materials 
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and attain higher purity, each EV pellet was resuspended once in PBS 
and recentrifuged under the same conditions that were originally used 
for pelleting. A simplified schematic representation of the EV isolation 
workflow is shown in the below Figure 2.  
 
Figure 2. Schematic summary of the EV isolation workflow 
To asses EV concentration and size, preparations as well 
ascell-depleted conditioned media were submitted to tunable resistive 
pulse sensing (TRPS) analysis using a qNano instrument (IZON 
Science, New Zealand). 
In order to characterize the morphology and size of the 
different EV preparations, EV pellets were submitted for transmission 
electron microscopy analysis using a Hitachi 7100 electron microscope 
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(Hitachi Ltd., Japan) equipped with a Megaview II (lower resolution, 
Soft Imaging System, Germany) digital camera. 
 For characterization of molecular markers present on EVs, 
APOs, MVs, and bead boud EXOs were analyzed by flow cytometry 
after incubation with different fluorochrome conjugated antibodies and 
affinity reagents. These included cholera toxin subunit B and di-4-
ANEPPDHQ, an anti-cholesterol antibody as well as annexin V, anti-
CD9, and anti-CD63 antibodies. To verify the vesicular nature of EVs, 
and to exclude the presence of antibody aggregates, we added Triton X-
100 to 0.05 % final concentration to the samples.  
Total protein content of EV preparations was determined using 
the commercially available bicinchoninic acid assay (BCA), Micro BCA 
Protein Assay Reagent Kit (Thermo Scientific, Rockford, IL), following 
the manufacturer’s specifications. 
 To measure total lipid content of EVs, the colorimetric reaction 
of sulfuric acid and phosphovanilin with lipids (Chabrol and Charonnat 
1937) was adapted for use in a 96 well plate format sulfophosphovanilin 
(SPV) assay using menhaden fish oil as a lipid standard. 
 In order to investigate the membrane lipid bilayer order of EV 
preparations, EVs were stained with the membrane probe Di-4-
ANEPPDHQ (Life Technologies) and analyzed by confocal microscopy 
(IX81 inverted microscope based Fluoview500 laser scanning confocal 
system and software; Olympus Europe, Hamburg, Germany) at 60x 




 Since one very important limitation when working with EVs is 
that typically the yields are much smaller than most other biological 
samples we first evaluated whether EV preparations could be detected 
in a 96 well plate adaptation of the SPV reaction using menhaden fish 
oil as a lipid standard. We found that with this adapted format the assay 
sensitivity is adequate for EV studies measuring samples containing as 
little as 0.5µg EVs either in dry pellet or in up to 50µL volume. 
Furthermore, we found that many of the compounds commonly found in 
cell line supernatants or biofluids from which EVs are isolated didn’t 
interfere strongly with the SPV and BCA assays. Notably, tryptophan 
interfered with the BCA assay and glucose interfered with both SPV and 
BCA assays. We also assessed the accuracy and variability of the SPV 
assay and compared it to those of the commonly used BCA assay 
finding that SPV assay compares favorably to the BCA assay in terms 
of accuracy, although showing slightly higher intra and inter-assay 
variabilities. However, at concentrations >50 µg/mL lipid for SPV or 
protein for Micro BCA, both assays show low variability and good 
accuracy. 
 Following isolation we characterized EV preparations by 
electron microscopy, flow cytometry, and tunable resistive pulse 
sensing finding typical morphology, size, and molecular markers.  
We next determined the lipid content of the EV preparations in 
parallel with protein determination by BCA assay. Using the values 
13 
 
obtained from BCA and SPV assessment, we calculated protein to lipid 
ratios of EV subpopulations isolated from different cell lines and human 
blood plasma and found this ratio to be characteristic of each respective 
EV subpopulation regardless of their cell origin. APOs were 
consistently characterized by the highest protein to lipid ratio followed 
by an intermediate ratio for MVs and the lowest ratio was in all cases 
found for EXOs. 
To test the applicability of protein to lipid ratio for quality 
control assessment we measured EVs in different conditions with 
suspected poor quality. Firstly, EVs from adenosine diphosphate 
induced platelets were tested.  The low speed (20,000 g) MV pellets 
were characterized by the expected protein to lipid ratios and the 
presence of MVs was confirmed by transmission electron microscopy. 
However, the protein to lipid ratios of the high speed “EXO” (100,000 
g) pellets were found to be abnormally elevated and electron 
microscopy showed the lack of any vesicular structures, suggesting that 
these “EXO” pellets were mostly composed of proteins. This was in line 
with the previous finding that ADP is a poor inducer of EXO production 
(Aatonen et al. 2014). Secondly, freshly isolated MVs incubated 
overnight at  
37 
o
C, a condition that we have found earlier to damage MV 
preparations. Protein to lipid ratios were determined before and after 
overnight incubation. The overnight incubated and re-pelleted MV 
preparations were characterized by abnormal protein to lipid ratios 
compared to the typical MV protein to lipid ratios measured for freshly 
isolated MVs. This was in agreement with the electron microscopy 
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showing vesicular damage following the overnight incubation. Finally 
MV preparations derived from red blood cell concentrates were 
compared after 2, 3, 4 or 5 consecutive washes showing a shift from 
elevated protein to lipid ratios to those expected for MVs after the third 
washing step suggesting the removal of contaminating proteins. 
To asses membrane lipid order of EVs, the GP value was 
calculated from the fluorescence intensities at 560-600 nm and 660 nm 
of samples stained by Di-4-ANEPPDHQ resulting in values between -1 
and +1 with higher GP values reflecting higher membrane lipid order 
(low liquid disordered, high liquid ordered structure). APOs and MVs 
were characterized by intermediate and partially overlapping lipid 
orders with GP values of -0.15 ± 0.15 and 0.00 ± 0.21 (median ± SEM), 
respectively. In contrast, EXOs displayed a GP value of 0.36 ± 0.29 
(median ± SEM), reflecting a higher degree of lipid order than either 
MVs or APOs (Figure 12). The observed GP values were also assessed 
by flow cytometry and the results were close to those of the confocal 
microscope measurement. The GP values measured by flow cytometry 
were -0.14, -0.14, and 0.25 for APOs, MVs, and EXOs, respectively 
(Figure 13). The differences between the GP values measured by 
confocal microscopy and flow cytometry could be ascribed to the small 
differences in the available filters in each instrument (560-600 nm and 
>660 nm in the confocal microscope as opposed to 585 ± 21 nm and 
616 ± 12 in the flow cytometer). However, the pattern of higher order in 
EXOs was observed by both instruments. 
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Detergent sensitivity of EV subpopulations was assessed by 
treatment with sodium dodecyl sulphate (SDS), Triton X-100, Tween 20 
and deoxycholate. All four detergents were found to lyse EVs albeit at 
different concentration ranges. EXOs were found to be the least 
sensitive to detergent lysis while APOs and MVs showed higher 
sensitivity to detergent lysis (and were similar to each other). Out of the 
four detergents, SDS was found to reduce APO and MV counts at the 
lowest concentrations (0.01 %) while Triton X-100 lysed EXOs at the 
lowest concentration (0.075 %). Interestingly, SDS lysed EXOs at least 
at an order of magnitude higher concentration (0.125 %) than required 
for lysing MVs and APOs (0.01 %). In contrast, EVs were the most 
resistant to treatment with Tween 20 which was found to reduce EV 
counts at very high concentrations (10-15 %) only. Similarly to Triton 






 The work of this Ph.D. dissertation was undertaken to establish 
for the first time a simple lipid assay for EVs and to find good quality 
control parameters to characterize EV preparations that might be 
utilized both in basic research and in clinical laboratory settings. To this 
end, we used and optimized the SPV total lipid assay for EV studies and 
combined this lipid assay with the conventional microBCA protein 
determination that is used widely in the EV field. Furthermore, we 
showed that if used under the optimized conditions described in this 
dissertation, the SPV assay sensitivity is adequate for EV studies. Using 
these two assays, we introduced protein to lipid ratio as a novel 
parameter to characterize EV preparations enriched in EXOs, MVs, and 
APOs. This parameter 
The spectral ratiometric approach of this study provides 
evidence that EV subpopulations can also be distinguished based on the 
difference in their membrane lipid order. Our data suggest that EXOs 
are characterized by highest membrane lipid order, while APOs and 
MVs showed low to intermediate, partially overlapping lipid order 
reflecting important differences in membrane lipid composition. A high 
degree of membrane lipid order and the relatively high content of 
cholesterol in EXOs may be important factors explaining their 
distinguished role in intercellular signaling as this is one of the most 
important biophysical parameters of membranes since in low ordered 
membrane domains the probability of protein-protein interactions is 
decreased (Owen et al. 2012).  
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Based on previous findings of our group, we also carried out a 
comprehensive analysis of the effect of detergents on size-based EV 
subpopulations. This work provides a practical tool to confirm the 
vesicular nature of particles present in biological samples using either 
TRPS or flow cytometry. Given that both TRPS and flow cytometry are 
commonly used methods to characterize EVs, the use of detergent 
control in EV analysis may prove useful in a wide variety of 
experimental settings and may also be combined with other techniques. 
We found that similar detergent concentrations lysed both APOs and 
MVs while higher concentrations were needed to lyse EXOs.  
These results point to the similarity of the lipid membrane 
composition of APOs and MVs as opposed to EXOs which were found 
to be more liquid ordered while both APOs and MVs had similar and 
lower membrane liquid orders. Accordingly, several studies show that 
liquid ordered as opposed to liquid-disordered membranes are resistant 
to detergents (Schroeder et al. 1994, Brown 1998). 
In conclusion, for the first time our work introduced a simple 
lipid assay and novel EV characterization parameter as well as the 
appropriate concentrations of different detergents to lyse EVs. We 
demonstrated that different size-based subpopulations of EVs secreted 
by highly diverse human cell lines show similar protein to lipid ratios, 
membrane lipid orders, and detergent sensitivity patterns. Taken 
together, our data validate the use of the SPV lipid assay, membrane 
lipid order assessment, and detergent lysis as integral components of the 
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